UK Companies House feature
12/14 PHARMACY LIMITED
Cash
£21K
+81.2% vs 2022
Net assets
£2M
+10.5% vs 2022
Employees
20
-16.7% vs 2022
Profit before tax
£373K
+7.9% vs 2022
Profile
- Company number
- 04416704
- Status
- Active
- Incorporation
- 2002-04-15
- Last accounts made up
- 2023-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2023-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £345,258 | £372,666 | |
| Net profit | — | — | — | — | £258,751 | £230,386 | |
| Cash | £254,650 | £240,917 | £910,959 | — | £11,350 | £20,562 | |
| Total assets less current liabilities | £148,765 | £264,228 | £1,234,425 | — | £4,138,152 | £3,899,110 | |
| Net assets | — | — | £1,234,425 | — | £2,199,036 | £2,429,422 | |
| Equity | £100 | £100 | £100 | £100 | £100 | £100 | |
| Average employees | — | 9 | 16 | — | 24 | 20 | |
| Wages | — | — | — | — | £517,892 | £539,503 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- TC Group
- Audit opinion
- Qualified
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- Al Zahra Medical Ltd
- Sakina Health Care Limited
Significant events
- “Brexit related price increases, covid related recruitment issues, drug price rises volatility, upcoming election with potential healthcare sector impact (page 4).”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAMANI, Zainab Pyarali | Secretary | 2002-04-15 | — | British |
| DAMANI, Zainab Pyarali | Director | 2002-04-15 | Dec 1955 | British |
| JESSA, Mohamed Jaffer | Director | 2002-04-15 | Aug 1966 | British |
| WALJI, Safil | Director | 2012-01-01 | Mar 1975 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 2002-04-15 | 2002-04-15 |
| NANJI, Mohamed Sherali Walji | Director | 2002-04-15 | 2011-05-09 |
| WALJI, Safil | Director | 2005-04-01 | 2005-04-01 |
| COMPANY DIRECTORS LIMITED | Corporate Nominee Director | 2002-04-15 | 2002-04-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Safil Walji | Individual | Significant influence | 2017-01-01 | Ceased 2019-04-15 |
| Sakina Health Care Ltd | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 86 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-09-09 | AA01 | accounts | change account reference date company previous extended |
| 2025-06-09 | AA | accounts | accounts with accounts type full |
| 2025-05-14 | DISS40 | gazette | gazette filings brought up to date |
| 2025-05-13 | GAZ1 | gazette | gazette notice compulsory |
| 2025-05-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-14 | AA01 | accounts | change account reference date company previous shortened |
| 2024-09-26 | AA01 | accounts | change account reference date company previous shortened |
| 2024-04-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-03-19 | CH01 | officers | change person director company with change date |
| 2023-12-11 | AA | accounts | accounts with accounts type total exemption full |
| 2023-10-04 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-06-09 | AD01 | address | change registered office address company with date old address new address |
| 2023-05-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-21 | AA | accounts | accounts with accounts type total exemption full |
| 2022-04-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-29 | AA | accounts | accounts with accounts type total exemption full |
| 2021-04-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-11-12 | AA | accounts | accounts with accounts type total exemption full |
| 2020-04-15 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ (private-firm) · reference 2023-12-31
4.53
SAFE
Altman Z″
- Working capital / Total assets 0.410 × 6.56 = +2.69
- Retained earnings / Total assets 0.283 × 3.26 = +0.92
- EBIT / Total assets 0.076 × 6.72 = +0.51
- Book equity / Total liabilities 0.395 × 1.05 = +0.42
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory